Finance entity
Sentiment skews less negative than the wider beat, at 0% negative against 26% across all 4459 Finance stories in the same window. Of the tracked stories, 5 of 11 also mention Weiss Ratings, the most common co-covered peer. That works out to roughly 0.4 stories per week across a 202-day span.
Last mentioned: 19h ago
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 9 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Sentiment skews less negative than the wider beat, at 0% negative against 26% across all 4459 Finance stories in the same window. Of the tracked stories, 5 of 11 also mention Weiss Ratings, the most common co-covered peer. That works out to roughly 0.4 stories per week across a 202-day span. markets accounts for 6 of the 11 tracked stories, while 2 other categories carry the remainder. Source depth averages 2.3 original sources per story, versus 2.7 across the same-window beat baseline. At 5.3, the average consequence score sits below the same-window beat average of 6.2. Jefferies Financial Group appears in 11 tracked Finance stories published from February 21, 2026 through September 10, 2026.
Computed from the 11 stories linked to this entity, with beat comparisons drawn from all 4459 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Jefferies Financial Group. Shared-story counts are live from our verified record — not editorial picks.
Wells Fargo Cuts Target to $70
Wells Fargo & Company lowers Freshpet’s price target from $75.00 to $70.00, keeping an Overweight rating, implying 28.42% upside.
Bank of America Lowers Target
Bank of America reduces its price target from $75.00 to $70.00 and maintains a Neutral rating.
Piper Sandler Stays Overweight
Piper Sandler reaffirms an Overweight rating on Freshpet shares.
Weiss Ratings Downgrades
Weiss Ratings cuts Freshpet from 'Hold (c)' to 'Hold (c-)'.
JPMorgan Upgrades, Others Reaffirm
JPMorgan raises rating from Neutral to Overweight and lifts target from $66.00 to $68.00. Morgan Stanley reiterates Overweight with $77.00 target, while Deutsche Bank holds at Hold with $63.00 target.
Jefferies Cuts Target
Jefferies Financial Group lowers its price objective from $75.00 to $70.00 and maintains a Hold rating.
TD Cowen Turns Bullish
TD Cowen upgrades Freshpet from Hold to Buy and sets an $80.00 price objective.
Oppenheimer Upgrades Freshpet
Oppenheimer raises Freshpet from Market Perform to Outperform with an $80.00 price target.
Jefferies' new equity strategy report frames India's next industrial cycle around six capital-intensive sectors. For investors, the call implies a thematic shift beyond IT services toward semiconductors, space, solar and data centre supply chains, backed by roughly $20 billion in triggered semiconductor investment.
Source: jamaicantimes.com · batonrougepost.com
Morgan Stanley trimmed its American Homes 4 Rent target to $38 from $38.50 while keeping an Overweight rating, against a $36.78 consensus and Moderate Buy average. Equity research actions from Jefferies, UBS, RBC, Mizuho, and Compass Point reveal a broadly constructive but price-sensitive stance on the REIT.
Source: themarketsdaily.com · tickerreport.com
BARK delivered a surprise $0.08 EPS, beating estimates by $0.48, sending its battered stock up to $11.25. With a $101.6M market cap and a consensus target of $15.33, the high-beta small-cap is drawing both institutional and retail interest.
Source: themarketsdaily.com · dailypolitical.com
EPAM Systems' Q3 EPS guidance of up to $3.46 topped consensus by 3.9%, while full-year profit view surged to $13.24, handily beating the $12.53 consensus. Despite a flat revenue outlook, the firm's improved profitability signals strong cost controls and could spark a re-rating of its discounted stock, now trading at 15.7x earnings.
Source: Ticker Report · Zolmax
Bloom Energy shares popped 6.5% on 46% higher volume to $219.22, reigniting the debate about its $62.36B valuation amid a bull-bear analyst divide. With price targets spanning $188 to $310 and a P/E near 292, the AI-driven stock offers high risk and high potential reward.
Wabtec guided revenue between $12.3-$12.6B and EPS slightly below the Street, while Moody’s EPS range also came in under estimates. Analysts remain constructive with moderate buy ratings and double-digit upside targets for both stocks.
Source: Bbns · Markets Daily
Monarch Casino & Resort posted a second-quarter earnings beat of $0.11 per share on revenue strength, driving the stock up 1.1% to $124.38. Valuation metrics remain solid with a P/E of 21.08 and a 1% dividend yield, but a recent CEO stock sale and mixed analyst ratings signal a cautious bias. Truist’s $144 price target offers the most bullish outlook, while Stifel sits at $102.
Source: MarketBeat · tickerreport.com
Wells Fargo lowered its price target on Freshpet to $70 from $75 while maintaining an Overweight rating, implying the stock is undervalued by 28%. The market remains skeptical with FRPT trading at $54.51, well below the consensus analyst target of $74.25. Analysts overall rate the pet food company a Moderate Buy, despite a string of recent target cuts.
Source: Watch List News · Ticker Report
A new Jefferies report warns that the massive AI infrastructure buildout is keeping U.S. inflation elevated, forcing markets to price in further rate hikes. Two-year Treasury yields just saw their biggest one-day jump in 14 months, and money markets now expect 36 basis points of tightening by year-end.
Zacks Research has issued rare 'Strong Sell' ratings for both Australian mining giant Fortescue and French luxury conglomerate Kering. The downgrades highlight deepening concerns over earnings estimate revisions and the companies' heavy exposure to a cooling Chinese economy.
Source: The Lincolnian Online · Bbns
AxoGen (NASDAQ: AXGN) has received a major boost from Wall Street as Wells Fargo upgraded the nerve-repair specialist to a 'Strong-Buy' rating. The upgrade follows a significant price target hike from Jefferies, signaling a robust consensus on the company's growth potential in the medical technology sector.
Jefferies Financial Group is linked from 11 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
